Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Exp Neurol. 2012 Dec 31;241:138–147. doi: 10.1016/j.expneurol.2012.12.013

Table 1.

VMAT2 WT and LO mice exposed to 30 mg/kg DE-71 for 30 days show an increase in brain concentrations of PBDE congeners.

BDE-28 BDE-47 BDE-66 BDE-85 BDE-99 BDE-100 BDE-153 BDE-154
WTCTL 0+0 0.004+0.004 0+0 0+0 0.01+0.003 0+0 0+0 0+0
LOCTL 0+0 0.01+0.01 0+0 0+0 0+0 0+0 0+0 0+0
WT DE-71 0+0 1.00+0.52 0.01+0.01 0.07+0.03 1.70+0.63 0.41+0.17 1.78+0.16 0.10+0.04
LO DE-71 0+0 0.19+0.08 0+0 0.03+.002 0.67+0.12 0.17+0.07 1.52+0.16 0.05+0.01

Data are expressed as mean ± SEM (4–6 animals per treatment group). Data are presented as mean PBDE congener levels (μg/g wet weight).